Gilbert Mikayla
Transaction: 02/01/2025
OTHER
Change
0
Price
Not reported
Filing
02/18/2025
Type
OTHER
Trees Corporation
CANN • Drug Manufacturers - Specialty & Generic
$0.02
▲ +0.00 (+9.04%)
Current price
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.97M
Growth
22.0%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 5.4%Weak liquidity · 0.08Weak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.02
Change9.04%
Shares Out108.75M
Market Cap$1.97M
Enterprise Value$17.71M
Beta-0.44
P/E-0.47
P/S0.14
P/B-0.64
P/FCF-2.79
EV/Sales1.30
EV/EBITDA20.85
Price$0.02
Change9.04%
Shares Out108.75M
Market Cap$1.97M
Enterprise Value$17.71M
Beta-0.44
P/E-0.47
P/S0.14
P/B-0.64
P/FCF-2.79
EV/Sales1.30
EV/EBITDA20.85
EV/FCF-25.13
Earnings Yield-211.03%
FCF Yield-35.81%
Dividend Yield1.10%
Gross Margin46.05%
Oper. Margin6.11%
Profit Margin-7.22%
Debt/Eq-5.80
Current Ratio0.08
Quick Ratio0.07
Revenue 5Y22.04%
Volume2.40K
Avg Volume120.20K
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
24/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
72/100
Price Attractiveness
Cheap or expensive today
68/100
Why this score▼
Positive revenue growth · 5.4%Weak liquidity · 0.08Weak profitability
Analyst view
No analyst data available now.
Financial Health
Score4 / 20
Debt / Equity: -5.80
Current Ratio: 0.08
Quick Ratio: 0.07
Status: HighRisk
Warnings
- Weak Liquidity
- Weak quick ratio
Insider Transactions
Recent executive and insider activity
⚠ 3 high-volume insider sells detected
TCM Tactical Opportunities Fund II LP
Transaction: 11/08/2024
SELL
Change
-4,912,349
Price
$0.40
Filing
02/06/2025
Type
SELL
Travia Richard C.
Transaction: 12/04/2024
BUY
Change
+75,000
Price
$0.04
Filing
12/06/2024
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Gilbert Mikayla | OTHER | 0 | Not reported | 02/01/2025 | 02/18/2025 |
| TCM Tactical Opportunities Fund II LP | SELL | -4,912,349 | $0.40 | 11/08/2024 | 02/06/2025 |
| Travia Richard C. | BUY | +75,000 | $0.04 | 12/04/2024 | 12/06/2024 |
| Williams Carl J | BUY | +50,000 | $0.04 | 12/04/2024 | 12/06/2024 |
| Williams Carl J | BUY | +50,000 | $0.10 | 08/29/2024 | 09/03/2024 |
| Travia Richard C. | BUY | +75,000 | $0.10 | 08/29/2024 | 09/03/2024 |
| TCM Tactical Opportunities Fund II LP | SELL | -5,710,566 | $0.50 | 03/16/2023 | 04/22/2024 |
| TCM Tactical Opportunities Fund II LP | SELL | -4,912,349 | $0.40 | 09/16/2022 | 04/22/2024 |
| Travia Richard C. | BUY | +214,815 | Not reported | 02/08/2024 | 02/09/2024 |
| Williams Carl J | BUY | +114,815 | Not reported | 02/08/2024 | 02/09/2024 |
| Travia Richard C. | BUY | +90,909 | Not reported | 11/09/2023 | 11/14/2023 |
| Williams Carl J | BUY | +90,909 | Not reported | 11/09/2023 | 11/14/2023 |
| Williams Carl J | BUY | +165,714 | Not reported | 07/31/2023 | 08/02/2023 |
| Travia Richard C. | BUY | +165,714 | Not reported | 07/31/2023 | 08/02/2023 |
| Williams Carl J | BUY | +90,625 | Not reported | 04/10/2023 | 04/12/2023 |
| Travia Richard C. | BUY | +90,625 | Not reported | 04/10/2023 | 04/12/2023 |
| Williams Carl J | BUY | +152,983 | Not reported | 02/06/2023 | 02/07/2023 |
| Travia Richard C. | BUY | +172,983 | Not reported | 02/06/2023 | 02/07/2023 |
| Brown Timothy Earl | SELL | 0 | Not reported | 09/07/2021 | 02/07/2023 |
| Downing Allyson Feiler | SELL | 0 | Not reported | 12/12/2022 | 12/22/2022 |